Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.

Abstract

BACKGROUND:

Dexamethasone cyclophosphamide pulse (DCP) therapy is an established mode of treatment for pemphigus in India.

AIMS:

To assess the therapeutic benefit of additional DCPs (phase II, consolidation phase) versus immediate oral cyclophosphamide, usually used in phase III (maintenance phase), after initial DCP therapy (phase I) and to assess which laboratory test (DIF or ELISA) will reflect the clinical relapse best.

METHODS:

Nineteen newly recruited patients of pemphigus vulgaris (PV) received monthly DCPs in phase I and were then randomized into two groups. Group A (10 patients) received monthly DCPs for nine months and Group B (nine patients) received only oral cyclophosphamide for nine months. Direct immunofluorescence (DIF) and enzyme-linked immunosorbent assay (ELISA) were tested before starting DCP regimen, and at 0,3,6,9 months after randomization.

RESULTS:

Clinical relapse by the end of follow-up period occurred in only one patient in each group. In these cases, DIF became (again) positive before the relapse. No statistically significant difference between the two groups was found at three, six and nine months by ELISA indices and DIF grading.

CONCLUSION:

Although the DCP regimen is the standard therapy for pemphigus in India, we found no difference in the clinical outcome between patients receiving nine DCPs in phase II and patients shifted directly from phase I to III. Periodic testing using DIF and Dsg ELISA were found to be useful to monitor disease activity and predict a relapse. Further large scale studies are required to assess if patients can be shifted directly from phase I to III and maintained only on oral cyclophosphamide.

• Authors: Nisha V Parmar, Amrinder J Kanwar, Ranjana W Minz, Davinder Parsad, Keshavamurthy Vinay, Daisuke Tsuruta, Norito Ishii, Takashi Hashimoto
• Journal: Indian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 2013 Jan-Feb Vol. 79 Issue 1 Pg. 70-6 ISSN: 0973-3922 [Electronic] United States
• PMID: 23254732 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Dexamethasone
• Cyclophosphamide

Topics

• Administration, Oral
• Adolescent
• Adult
• Cyclophosphamide (administration & dosage)
• Dexamethasone (administration & dosage)
• Drug Therapy, Combination
• Enzyme-Linked Immunosorbent Assay
• Female
• Fluorescent Antibody Technique
• Humans
• India
• Male
• Middle Aged
• Pemphigus (drug therapy)
• Pulse Therapy, Drug (methods)
• Treatment Outcome
• Young Adult